Drug-carrying properties and targeted delivery of biomimetic nanoparticles delivering wild baicalin and Adriamycin

The extensive application of biomaterials and nanotechnology in biomedical technology can enhance the drug-carrying performance and targeted therapeutic ability of drug nanoparticles. In the article, biomimetic nanoparticles of wild baicalin and adriamycin were prepared based on conventional means, and the drug release performance of SCU/DOX was analysed using drug release kinetics and the inhibitory effect of SCU/DOX nanoparticles on tumour cells. The nanoparticles were produced through nanotechnology after the main experimental scheme was prepared for the preparation of the basic medicine. At the same time, the study combines the biological electrical signal to obtain the value of the relevant measurement index. When the SCU/DOX nanodrug concentration was elevated from 10 μM to 16010 μM, the viability of mouse tumour cells was reduced from 82.54% to about 47.69%. This shows that nanoparticles can effectively deliver drugs. After the use of SCU drug alone and SCU/DOX nanoparticles, the IC50 values of both were 59.42 μM and 8.75 μM, respectively, with a reversal of resistance multiplier of 6.79-fold. Tumour cell treatment with SCU/DOX nanoparticles reduced the tumour volume from 15.1*102mm3 to 6.05*102mm3 and tumour weight by 64.14% in mice. The cumulative drug release from SCU/DOX nanoparticles was 11.18% at 2h, and higher than that of the esterase-free condition after 20h (17.61%). The data of the cumulative release of the drug show that the release of biomimetic nanoparticles can actually target the target. The unique quality of nanomaterials can allow drugs to release drugs in the set target environment. On the basis of this study, if clinical trials can also achieve good results, they are expected to be applied in practice. The preparation of baicalin and adriamycin mimetic nanoparticles based on the drug delivery system can enhance the drug-carrying property and target delivery effect of the drug, which can provide a reliable technical support to enhance the therapeutic effect of the disease.

Authors

Institutions

Publication Details

Journal
Molecular & cellular biomechanics
Published
2024-12-26
DOI
https://doi.org/10.62617/mcb661
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-carrying properties and targeted delivery of biomimetic nanoparticles delivering wild baicalin and Adriamycin

Songwei Zhao, Menglu Wang, Yulin Li
Molecular & cellular biomechanics
Flavonoids in Medical Research
article

Drug-carrying properties and targeted delivery of biomimetic nanoparticles delivering wild baicalin and Adriamycin

Songwei Zhao, Menglu Wang, Yulin Li
article en

Abstract

The extensive application of biomaterials and nanotechnology in biomedical technology can enhance the drug-carrying performance and targeted therapeutic ability of drug nanoparticles. In the article, biomimetic nanoparticles of wild baicalin and adriamycin were prepared based on conventional means, and the drug release performance of SCU/DOX was analysed using drug release kinetics and the inhibitory effect of SCU/DOX nanoparticles on tumour cells. The nanoparticles were produced through nanotechnology after the main experimental scheme was prepared for the preparation of the basic medicine. At the same time, the study combines the biological electrical signal to obtain the value of the relevant measurement index. When the SCU/DOX nanodrug concentration was elevated from 10 μM to 16010 μM, the viability of mouse tumour cells was reduced from 82.54% to about 47.69%. This shows that nanoparticles can effectively deliver drugs. After the use of SCU drug alone and SCU/DOX nanoparticles, the IC50 values of both were 59.42 μM and 8.75 μM, respectively, with a reversal of resistance multiplier of 6.79-fold. Tumour cell treatment with SCU/DOX nanoparticles reduced the tumour volume from 15.1*102mm3 to 6.05*102mm3 and tumour weight by 64.14% in mice. The cumulative drug release from SCU/DOX nanoparticles was 11.18% at 2h, and higher than that of the esterase-free condition after 20h (17.61%). The data of the cumulative release of the drug show that the release of biomimetic nanoparticles can actually target the target. The unique quality of nanomaterials can allow drugs to release drugs in the set target environment. On the basis of this study, if clinical trials can also achieve good results, they are expected to be applied in practice. The preparation of baicalin and adriamycin mimetic nanoparticles based on the drug delivery system can enhance the drug-carrying property and target delivery effect of the drug, which can provide a reliable technical support to enhance the therapeutic effect of the disease.

Molecular & cellular biomechanicsVol. 21(4)
Ningbo Polytechnic (CN)
Openalex Percentile: Top 76%
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Drug-carrying properties and targeted delivery of biomimetic nanoparticles delivering wild baicalin and Adriamycin — Songwei Zhao, Menglu Wang, et al. · Molecular & cellular biomechanics (2024) | TGRS Research Map | TGRS